EP300 and diabetes mellitus: Interestingly, overexpression of miR-200b abrogates diabetes-induced increased expression of p300, a target of miR-200b, along with other EndMT markers/regulators, and cardiac fibrosis, and that is associated with improvement of diabetes-induced cardiac functional and structural abnormalities.